{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:27:57Z","timestamp":1785796077679,"version":"3.56.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s11916-024-01248-0","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T12:01:47Z","timestamp":1712059307000},"page":"587-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients"],"prefix":"10.1007","volume":"28","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Dufrene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jada","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"1248_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"\u2022 van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437\u201349. https:\/\/doi.org\/10.1093\/annonc\/mdm056. Cancer pain remains a significant problem with >50% of cancer patients suffering from chronic pain.","journal-title":"Ann Oncol"},{"key":"1248_CR2","doi-asserted-by":"publisher","unstructured":"Dalal S, Bruera E. Pain management for patients with advanced cancer in the opioid epidemic era. American Society Of Clinical Oncology Educational Book.\u00a02019;39-39. https:\/\/doi.org\/10.1200\/EDBK_100020","DOI":"10.1200\/EDBK_100020"},{"key":"1248_CR3","first-page":"71","volume":"7","author":"AN Carmichael","year":"2016","unstructured":"\u2022 Carmichael AN, Morgan L, Del Fabbro E. Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review. Subst Abuse Rehabil. 2016;7:71\u20139. One in five cancer patients was found to be at risk of opioid use disorder.","journal-title":"Subst Abuse Rehabil"},{"key":"1248_CR4","unstructured":"Murthy VH. Letter from United States Surgeon General Vivek H. Murthy, MD, MBA, August 2016. http:\/\/i2.cdn.turner.com\/cnn\/2016\/images\/08\/25\/sg.opioid.letter.pdf. Accessed 28 Feb. 2024."},{"key":"1248_CR5","doi-asserted-by":"publisher","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1\u201395.\u00a0https:\/\/doi.org\/10.15585\/mmwr.rr7103a1","DOI":"10.15585\/mmwr.rr7103a1"},{"issue":"5","key":"1248_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.12968\/ijpn.2021.27.5.255","volume":"27","author":"J. R Borders","year":"2021","unstructured":"Borders J. R, Letvak S, Amirehsani K. A, Ross R, Phifer N. Opioid epidemic and prescribing in hospice and palliative care: a review of the literature. Int J Palliat Nurs. 2021;27(5):255\u201361. https:\/\/doi.org\/10.12968\/ijpn.2021.27.5.255.","journal-title":"Int. J. Palliat. Nurs"},{"issue":"9","key":"1248_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/1049909119897260","volume":"37","author":"MZ Al-Shahri","year":"2020","unstructured":"Al-Shahri MZ, Abdullah A, Alansari A, Sroor M. Opioid prescribing patterns before and after an inpatient palliative care consultation. Am J Hosp Palliat Med. 2020;37(9):738\u201342. https:\/\/doi.org\/10.1177\/1049909119897260.","journal-title":"Am J Hosp Palliat Med"},{"issue":"2","key":"1248_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","volume":"186","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhuang Y, DiBerto JF, et al. Structures of the entire human opioid receptor family. Cell. 2023;186(2):413-427.e17. https:\/\/doi.org\/10.1016\/j.cell.2022.12.026.","journal-title":"Cell"},{"key":"1248_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2022.1014768","author":"JA Higginbotham","year":"2022","unstructured":"Higginbotham JA, Markovic T, Massaly N, Mor\u00f3n JA. Endogenous opioid systems alterations in pain and opioid use disorder. Front Syst Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnsys.2022.1014768.","journal-title":"Front Syst Neurosci"},{"issue":"1","key":"1248_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/bja\/aer115","volume":"107","author":"N Dietis","year":"2011","unstructured":"Dietis N, Rowbotham DJ, Lambert DG. Opioid receptor subtypes: fact or artifact? Br J Anaesth. 2011;107(1):8\u201318. https:\/\/doi.org\/10.1093\/bja\/aer115.","journal-title":"Br J Anaesth"},{"issue":"2","key":"1248_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1124\/mol.120.119388","volume":"98","author":"LD Fricker","year":"2020","unstructured":"Fricker LD, Margolis EB, Gomes I, Devi LA. Five decades of research on opioid peptides: current knowledge and unanswered questions. Mol Pharmacol. 2020;98(2):96\u2013108. https:\/\/doi.org\/10.1124\/mol.120.119388.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1248_CR12","first-page":"132","volume":"21","author":"JC Froehlich","year":"1997","unstructured":"Froehlich JC. Opioid peptides. Alcohol Health Res World. 1997;21(2):132\u20136.","journal-title":"Alcohol Health Res World"},{"issue":"1","key":"1248_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10989-019-09813-7","volume":"26","author":"J Kaur","year":"2020","unstructured":"Kaur J, Kumar V, Sharma K, et al. Opioid peptides: an overview of functional significance. Int J Pept Res Ther. 2020;26(1):33\u201341. https:\/\/doi.org\/10.1007\/s10989-019-09813-7.","journal-title":"Int J Pept Res Ther"},{"issue":"1","key":"1248_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev-biochem-061620-044044","volume":"90","author":"T Che","year":"2021","unstructured":"Che T, Roth BL. Structural insights accelerate the discovery of opioid alternatives. Annu Rev Biochem. 2021;90(1):739\u201361. https:\/\/doi.org\/10.1146\/annurev-biochem-061620-044044.","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"1248_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2049463720911986","volume":"14","author":"A James","year":"2020","unstructured":"James A, Williams J. Basic opioid pharmacology \u2014 an update. Br J Pain. 2020;14(2):115\u201321. https:\/\/doi.org\/10.1177\/2049463720911986.","journal-title":"Br J Pain"},{"key":"1248_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.919773","volume":"15","author":"KC Reeves","year":"2022","unstructured":"Reeves KC, Shah N, Mu\u00f1oz B, Atwood BK. Opioid receptor-mediated regulation of neurotransmission in the brain. Front Mol Neurosci. 2022;15: 919773. https:\/\/doi.org\/10.3389\/fnmol.2022.919773.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"1248_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.789","volume":"9","author":"F Khan","year":"2021","unstructured":"Khan F, Mehan A. Addressing opioid tolerance and opioid-induced hypersensitivity: recent developments and future therapeutic strategies. Pharmacol Res Perspect. 2021;9(3): e00789. https:\/\/doi.org\/10.1002\/prp2.789.","journal-title":"Pharmacol Res Perspect"},{"key":"1248_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00052","author":"B Quirion","year":"2020","unstructured":"Quirion B, Bergeron F, Blais V, Gendron L. The delta-opioid receptor; a target for the treatment of pain. Front Mol Neurosci. 2020.\u00a0https:\/\/doi.org\/10.3389\/fnmol.2020.00052","journal-title":"Front Mol Neurosci"},{"key":"1248_CR19","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/AJP.0b013e3181c49e3a","volume":"26","author":"TW Vanderah","year":"2010","unstructured":"Vanderah TW. Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain. 2010;26:S10. https:\/\/doi.org\/10.1097\/AJP.0b013e3181c49e3a.","journal-title":"Clin J Pain"},{"issue":"2","key":"1248_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","volume":"124","author":"CJ Hayhurst","year":"2016","unstructured":"Hayhurst CJ, Durieux ME. Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality. Anesthesiology. 2016;124(2):483\u20138. https:\/\/doi.org\/10.1097\/ALN.0000000000000963.","journal-title":"Anesthesiology"},{"issue":"4","key":"1248_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMra1800222","volume":"380","author":"JAJ Martyn","year":"2019","unstructured":"Martyn JAJ, Mao J, Bittner EA. Opioid tolerance in critical illness. N Engl J Med. 2019;380(4):365\u201378. https:\/\/doi.org\/10.1056\/NEJMra1800222.","journal-title":"N Engl J Med"},{"issue":"22","key":"1248_CR22","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMp2211040","volume":"387","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. Prescribing opioids for pain \u2014 the new CDC clinical practice guideline. N Engl J Med. 2022;387(22):2011\u20133. https:\/\/doi.org\/10.1056\/NEJMp2211040.","journal-title":"N Engl J Med"},{"issue":"6","key":"1248_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40263-022-00924-2","volume":"36","author":"F Coluzzi","year":"2022","unstructured":"Coluzzi F, Rullo L, Scerpa MS, et al. Current and future therapeutic options in pain management: multi-mechanistic opioids involving both MOR and NOP receptor activation. CNS Drugs. 2022;36(6):617\u201332. https:\/\/doi.org\/10.1007\/s40263-022-00924-2.","journal-title":"CNS Drugs"},{"issue":"12","key":"1248_CR24","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/pm\/pnaa089","volume":"21","author":"A Lazaridou","year":"2020","unstructured":"Lazaridou A, Paschali M, Edwards RR, Gilligan C. Is buprenorphine effective for chronic pain? A systematic review and meta-analysis. Pain Med. 2020;21(12):3691\u20139. https:\/\/doi.org\/10.1093\/pm\/pnaa089.","journal-title":"Pain Med"},{"issue":"9","key":"1248_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34540","volume":"6","author":"LC Chambers","year":"2023","unstructured":"Chambers LC, Hallowell BD, Zullo AR, et al. Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl. JAMA Netw Open. 2023;6(9): e2334540. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.34540.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1248_CR26","doi-asserted-by":"publisher","first-page":"44998","DOI":"10.4088\/PCC.21r03223","volume":"25","author":"JS Konakanchi","year":"2023","unstructured":"Konakanchi JS, Sethi R. The growing epidemic of opioid use disorder in the elderly and its treatment: a review of the literature. Prim Care Companion CNS Disord. 2023;25(1):44998. https:\/\/doi.org\/10.4088\/PCC.21r03223.","journal-title":"Prim Care Companion CNS Disord"},{"key":"1248_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2021.100050","volume":"3","author":"CA Cadogan","year":"2021","unstructured":"Cadogan CA, Murphy M, Boland M, Bennett K, McLean S, Hughes C. Prescribing practices, patterns, and potential harms in patients receiving palliative care: a systematic scoping review. Explor Res Clin Soc Pharm. 2021;3: 100050. https:\/\/doi.org\/10.1016\/j.rcsop.2021.100050.","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"2","key":"1248_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jpainsymman.2015.09.003","volume":"51","author":"MJ McNeil","year":"2016","unstructured":"McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage. 2016;51(2):178-183.e2. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.09.003.","journal-title":"J Pain Symptom Manage"},{"issue":"13","key":"1248_CR29","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","volume":"170","author":"G Onder","year":"2010","unstructured":"Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142\u20138. https:\/\/doi.org\/10.1001\/archinternmed.2010.153.","journal-title":"Arch Intern Med"},{"issue":"2","key":"1248_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11096-020-01191-1","volume":"43","author":"AA Al-Qurain","year":"2021","unstructured":"\u2022 Al-Qurain AA, Gebremichael LG, Khan MS, et al. Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia. Int J Clin Pharm. 2021;43(2):365\u201374. Strong opioids were prescribed more frequently than weak opioids, and opioid users had an increase in risk of opioid-related adverse effects.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"1248_CR31","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1634\/theoncologist.2019-0085","volume":"25","author":"S Hong","year":"2020","unstructured":"Hong S, Lee JH, Chun EK, et al. Polypharmacy, inappropriate medication use, and drug interactions in older Korean patients with cancer receiving first-line palliative chemotherapy. Oncologist. 2020;25(3):e502\u201311. https:\/\/doi.org\/10.1634\/theoncologist.2019-0085.","journal-title":"Oncologist"},{"key":"1248_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2016.11.003","volume":"73","author":"SP Stumbo","year":"2017","unstructured":"Stumbo SP, Yarborough BJH, McCarty D, Weisner C, Green CA. Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement. J Subst Abuse Treat. 2017;73:47\u201354. https:\/\/doi.org\/10.1016\/j.jsat.2016.11.003.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"1248_CR33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/bjp.2008.100","volume":"154","author":"MJ Christie","year":"2008","unstructured":"Christie MJ. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 2008;154(2):384\u201396. https:\/\/doi.org\/10.1038\/bjp.2008.100.","journal-title":"Br J Pharmacol"},{"key":"1248_CR34","unstructured":"Shah M, Huecker MR. Opioid withdrawal. In: StatPearls. StatPearls Publishing; 2024.\u00a0 Accessed\u00a01 March. 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526012\/"},{"issue":"2","key":"1248_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jsat.2014.03.004","volume":"47","author":"RD Weiss","year":"2014","unstructured":"Weiss RD, Potter JS, Griffin ML, et al. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J Subst Abuse Treat. 2014;47(2):140\u20135. https:\/\/doi.org\/10.1016\/j.jsat.2014.03.004.","journal-title":"J Subst Abuse Treat"},{"key":"1248_CR36","unstructured":"Dydyk AM, Jain NK, Gupta M. Opioid use disorder. In: StatPearls. StatPearls Publishing; 2024. Accessed 1 March. 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553166\/"},{"issue":"1","key":"1248_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","volume":"26","author":"ND Volkow","year":"2021","unstructured":"Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2021;26(1):218\u201333. https:\/\/doi.org\/10.1038\/s41380-020-0661-4.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1248_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/ajad.12862","volume":"28","author":"TR Kosten","year":"2019","unstructured":"\u2022 Kosten TR, Baxter LE. Review article: Effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment. Am J Addict. 2019;28(2):55\u201362. https:\/\/doi.org\/10.1111\/ajad.12862. The use of \u03b1\u20102 adrenergic agonists can help in tapering opioids in opioid-dependent patients.","journal-title":"Am J Addict"},{"issue":"18","key":"1248_CR39","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMra020617","volume":"348","author":"TR Kosten","year":"2003","unstructured":"Kosten TR, O\u2019Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348(18):1786\u201395. https:\/\/doi.org\/10.1056\/NEJMra020617.","journal-title":"N Engl J Med"},{"issue":"8","key":"1248_CR40","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00204-021-03068-2","volume":"95","author":"BA Baldo","year":"2021","unstructured":"Baldo BA. Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity. Arch Toxicol. 2021;95(8):2627\u201342. https:\/\/doi.org\/10.1007\/s00204-021-03068-2.","journal-title":"Arch Toxicol"},{"issue":"6","key":"1248_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","volume":"100","author":"KTS Pattinson","year":"2008","unstructured":"Pattinson KTS. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747\u201358. https:\/\/doi.org\/10.1093\/bja\/aen094.","journal-title":"Br J Anaesth"},{"key":"1248_CR42","doi-asserted-by":"publisher","unstructured":"Bachmutsky I, Wei XP, Kish E, Yackle K. Opioids depress breathing through two small brainstem sites. Calabrese RL, Ramirez JM, Montandon G, Smith JC, eds. eLife. 2020;9:e52694.\u00a0https:\/\/doi.org\/10.7554\/eLife.52694","DOI":"10.7554\/eLife.52694"},{"issue":"11","key":"1248_CR43","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112\u201320. https:\/\/doi.org\/10.1056\/NEJMra041867.","journal-title":"N Engl J Med"},{"issue":"9","key":"1248_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","volume":"96","author":"EJC Dunkley","year":"2003","unstructured":"Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM Int J Med. 2003;96(9):635\u201342. https:\/\/doi.org\/10.1093\/qjmed\/hcg109.","journal-title":"QJM Int J Med"},{"key":"1248_CR45","doi-asserted-by":"publisher","unstructured":"Gillman K, Whyte IM. Serotonin syndrome. In: Haddad P, Dursun S, Deakin B, eds. Adverse syndromes and psychiatric drugs: a clinical guide. Oxford University Press; 2004:0.\u00a0https:\/\/doi.org\/10.1093\/med\/9780198527480.003.0003","DOI":"10.1093\/med\/9780198527480.003.0003"},{"key":"1248_CR46","unstructured":"Serotonin toxicity: a practical approach to diagnosis and treatment - Isbister - 2007 - Medical Journal of Australia - Wiley Online Library. Accessed 1 March. 2024.\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.5694\/j.1326-5377.2007.tb01282.x"},{"issue":"6","key":"1248_CR47","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1176\/ajp.148.6.705","volume":"148","author":"The serotonin syndrome","year":"1991","unstructured":"The serotonin syndrome. Am J Psychiatry. 1991;148(6):705\u201313. https:\/\/doi.org\/10.1176\/ajp.148.6.705.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1248_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bja.2019.08.010","volume":"124","author":"BA Baldo","year":"2020","unstructured":"\u2022 Baldo BA, Rose MA. The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. Br J Anaesth. 2020;124(1):44\u201362. Opioids such as tramadol can cause serotonin syndrome via inhibition of the serotonin transporter.","journal-title":"Br J Anaesth"},{"issue":"3","key":"1248_CR49","first-page":"1263","volume":"274","author":"EE Codd","year":"1995","unstructured":"Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995;274(3):1263\u201370.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"1248_CR50","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3122\/jabfm.2016.06.160073","volume":"29","author":"LA Grande","year":"2016","unstructured":"Grande LA, Thompson EC, Au MA, Sawyer D, Baldwin L-M, Rosenblatt R. Problem drug-related behavior and discontinuation of opioids following the introduction of an opioid management program. The Journal of the American Board of Family Medicine. 2016;29(6):718\u201326. https:\/\/doi.org\/10.3122\/jabfm.2016.06.160073.","journal-title":"The Journal of the American Board of Family Medicine"},{"issue":"2","key":"1248_CR51","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11606-017-4211-y","volume":"33","author":"JS Merlin","year":"2018","unstructured":"Merlin JS, Young SR, Starrels JL, Azari S, Edelman EJ, Pomeranz J, Roy P, Saini S, Becker WC, Liebschutz JM. Managing concerning behaviors in patients prescribed opioids for chronic pain: a Delphi study. J Gen Intern Med. 2018;33(2):166\u201376. https:\/\/doi.org\/10.1007\/s11606-017-4211-y.","journal-title":"J Gen Intern Med"},{"issue":"14","key":"1248_CR52","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1111\/bph.13812","volume":"175","author":"L Nummenmaa","year":"2018","unstructured":"Nummenmaa L, Tuominen L. Opioid system and human emotions. Br J Pharmacol. 2018;175(14):2737\u201349. https:\/\/doi.org\/10.1111\/bph.13812.","journal-title":"Br J Pharmacol"},{"key":"1248_CR53","unstructured":"Stellern, J., Xiao, K.B.,Grennell, E., Sanches, M., Gowin, J.L., Sloan, M.E., (n.d.). Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction (Abingdon, England). https:\/\/pubmed.ncbi.nlm.nih.gov\/35851975\/"},{"issue":"6","key":"1248_CR54","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.genhosppsych.2012.06.018","volume":"34","author":"JO Merrill","year":"2012","unstructured":"Merrill JO, Von Korff M, Banta-Green CJ, Sullivan MD, Saunders KW, Campbell CI, Weisner C. Prescribed opioid difficulties, depression, and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012;34(6):581\u20137.","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"1248_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1017\/S0033291720002160","volume":"52","author":"J Santaella-Tenorio","year":"2022","unstructured":"Santaella-Tenorio J, Martins SS, Cerd\u00e1 M, Olfson M, Keyes KM. Suicidal ideation and attempts following nonmedical use of prescription opioids and related disorder. Psychol Med. 2022;52(2):372\u20138. https:\/\/doi.org\/10.1017\/S0033291720002160.","journal-title":"Psychol Med"},{"issue":"6","key":"1248_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40266-017-0455-9","volume":"34","author":"LM Swart","year":"2017","unstructured":"Swart LM, van der Zanden V, Spies PE, de Rooij SE, van Munster BC. The comparative risk of delirium with different opioids: a systematic review. Drugs Aging. 2017;34(6):437\u201343.","journal-title":"Drugs Aging"},{"issue":"2","key":"1248_CR57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpainsymman.2014.05.009","volume":"48","author":"SH Bush","year":"2014","unstructured":"Bush SH, Leonard MM, Agar M, et al. End-of-life delirium: issues regarding recognition, optimal management, and the role of sedation in the dying phase. J Pain Symptom Manage. 2014;48(2):215\u201330. https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.05.009.","journal-title":"J Pain Symptom Manage"},{"issue":"15","key":"1248_CR58","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s40265-017-0804-3","volume":"77","author":"SH Bush","year":"2017","unstructured":"\u2022 Bush SH, Tierney S, Lawlor PG. Clinical assessment and management of delirium in the palliative care setting. Drugs. 2017;77(15):1623\u201343. Delirium is present in up to 42% of palliative care patients.","journal-title":"Drugs"},{"key":"1248_CR59","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/anae.13090","volume":"70","author":"N Rughooputh","year":"2015","unstructured":"Rughooputh N, Griffiths R. Tramadol and delirium. Anaesthesia. 2015;70:632\u20133.","journal-title":"Anaesthesia"},{"key":"1248_CR60","doi-asserted-by":"crossref","unstructured":"\u2022 Godwin B, Frank C, Molnar F, Dyks D, Akter R. Identification and management of opioid-induced neurotoxicity in older adults. The College of Family Physicians of Canada. 2022. Canadians >65 years of age have a higher likelihood of being on opioids long-term.","DOI":"10.46747\/cfp.6804269"},{"key":"1248_CR61","first-page":"426","volume":"53","author":"R Gallagher","year":"2007","unstructured":"Gallagher R. Opioid-induced neurotoxicity. Can Fam Physician. 2007;53:426\u20137.","journal-title":"Can Fam Physician"},{"issue":"12","key":"1248_CR62","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1089\/jpm.2018.0169","volume":"21","author":"KH Lim","year":"2018","unstructured":"\u2022 Lim KH, Nguyen NN, Qian Y, Williams JL, Lui DD, Bruera E, Yennurajalingam S. Frequency, outcomes, and associated factors for opioid-induced neurotoxicity in patients with advanced cancer receiving opioids in inpatient palliative care. J Palliat Med. 2018;21(12):1698\u2013704. Opioid-induced neurotoxicity was found in 15% of inpatient palliative care patients receiving opioid treatment.","journal-title":"J Palliat Med"},{"issue":"9","key":"1248_CR63","volume":"15","author":"C Gharibo","year":"2023","unstructured":"Gharibo C, Drewes AM, Breve F, Rekatsina M, Narvaez Tamayo MA, Varrassi G, Paladini A. Iatrogenic side effects of pain therapies. Cureus. 2023;15(9): e44583.","journal-title":"Cureus"},{"issue":"3","key":"1248_CR64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0885-3924(00)00109-3","volume":"19","author":"SD Passik","year":"2000","unstructured":"Passik SD, Theobald DE. Managing addiction in advanced cancer patients: why bother? J Pain Symptom Manage. 2000;19(3):229\u201334.","journal-title":"J Pain Symptom Manage"},{"key":"1248_CR65","unstructured":"Sun C, Wang YT, Dai YJ, Liu ZH, Yang J, Cheng ZQ, Dong DS, Wang CF, Zhao GL, Lu GJ, Song T, Jin Y, Sun LL, Kaye AD, Urits I, Viswanath O, Sun YH. Intrathecal morphine delivery at cisterna magna to control refractory cancer-related pain: a prospective cohort study. Psychopharmacol Bull. 2020 Oct 15;50(4 Suppl 1):48\u201366. PMID: 33633417; PMCID: PMC7901124."},{"key":"1248_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113871","volume":"156","author":"CG Virgen","year":"2022","unstructured":"Virgen CG, Kelkar N, Tran A, Rosa CM, Cruz-Topete D, Amatya S, Cornett EM, Urits I, Viswanath O, Kaye AD. Pharmacological management of cancer pain: novel therapeutics. Biomed Pharmacother. 2022;156: 113871. https:\/\/doi.org\/10.1016\/j.biopha.2022.113871. (Epub 2022 Oct 19 PMID: 36272265).","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1248_CR67","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bpa.2020.06.003","volume":"34","author":"K Gress","year":"2020","unstructured":"Gress K, Charipova K, Jung JW, Kaye AD, Paladini A, Varrassi G, Viswanath O, Urits I. A comprehensive review of partial opioid agonists for the treatment of chronic pain. Best Pract Res Clin Anaesthesiol. 2020;34(3):449\u201361. https:\/\/doi.org\/10.1016\/j.bpa.2020.06.003. (Epub 2020 Jul 2 PMID: 33004158).","journal-title":"Best Pract Res Clin Anaesthesiol"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01248-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-024-01248-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01248-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T09:13:35Z","timestamp":1721466815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-024-01248-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1007\/s11916-024-01248-0","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"19 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Alan D. Kaye is an editor-in-chief for Current Pain and Headache Reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}